HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

4th Edition of World Congress on Infectious Diseases

June 21-22, 2023 | Rome, Italy

June 21 -22, 2023 | Rome, Italy

Infection 2023

Speaker at World Congress on Infectious Diseases 2023 - Stephen Hsu
Keynote Presentation (In-person)
Stephen Hsu, Augusta University, United States

Background: Severe Acute Respiratory Syndrome (SARS) coronavirus 2 (SARS-CoV-2) is responsible for the 2019 coronavirus epidemic (COVID-19). SARS-CoV-2 infection is associated with high mortality and morbidity worldwide. By Dec 1, 2022, over 643 million cases have been reported w [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Inchauspe Genevieve
Keynote Presentation (In-person)
Inchauspe Genevieve, ImmunResQ Department, Transgene, France

A famous milestone in the vaccine field has been the first successful vaccination against smallpox in 1798 by Edward Jenner. Using the vaccinia cowpox virus, Jenner was able to protect vaccinees from variola or smallpox. The Modified Virus Ankara (MVA) poxvirus strain has been on [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Walter Fabricio Silva Martins
Oral Presentation (In-person)
Walter Fabricio Silva Martins, LSTM, United Kingdom

Aedes aegypti is the most important vector of at least four fatal and/or debilitating arboviruses (dengue, chikungunya, yellow fever and Zika). Insecticide-based approaches remain the major intervention to minimize vector-borne disease burden across the diseases. In Brazil [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Paulo Arroyo
Oral Presentation (In-person)
Paulo Arroyo, Warwick Medical School, United Kingdom

Objectives:  Although several studies have shown that the application of antimicrobial stewardship (AMS) has a positive impact on reduction of antimicrobial resistance and therefore the clinical outcomes of patients, most of the studies were conducted some years ago, and [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Giancarlo Biagini
Oral Presentation (In-person)
Giancarlo Biagini, Liverpool School of Tropical Medicine, United Kingdom

Soon after SARS-CoV-2 was recognised as a pandemic threat, we set out to pioneer technologies to fast-track and de-risk advanced drug development. Our highly innovative models offers industry access to pioneering technologies which support the development of game-changing nove [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Rickyle Christopher Balea
Oral Presentation (In-person)
Rickyle Christopher Balea, The University of the Sunshine Coast, Australia

Zika virus (ZIKV) is a re-emerging flavivirus that poses a significant public health threat. ZIKV exhibits a wide array of non-vector borne human transmission routes, such as sexual transmission, transplacental transmission and blood transfusion. Detection and surveillance of ZIK [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Valeria Di Lollo
Oral Presentation (In-person)
Valeria Di Lollo, Istituto Zooprofilattico Sperimentale (IZS), Italy

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the ongoing outbreak of the disease known as coronavirus disease 2019 (COVID-19). The genetic plasticity of SARS-CoV-2 has determined the emergence of numerous variants with enhanced adaptive c [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Alfonso Recordare
Oral Presentation (In-person)
Alfonso Recordare, Dell Angelo Hospital, Italy

Difficult-to-treat infections have led to a renewed interest in phage therapy as adjunct to conventional surgical and antimicrobials treatments. Chronic bone infections are biofilm-related infections difficult to eradicate; in vitro data indicate that phages are active against bi [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Pietro Salvatori
Oral Presentation (In-person)
Pietro Salvatori, Private Practice, Italy

Background: This study was designed to evaluate the efficacy and safety of nebulized ethanol (EtOH) in the treatment of COVID-19. Methods: A RCT of 99 symptomatic and RT-PCR-positive patients admitted to a hospital receiving Remdesevir-Dexamethasone was conducted. They were ra [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Pietro Salvatori
Oral Presentation (In-person)
Pietro Salvatori, Private Practice, Italy

The severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic is a major health concern affecting socio-economic lives. As with other highly contagious diseases, it is of utmost importance to identify and treat the healthy carriers or positive asymptomatic subjects (P [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Sara Sentre Domingo
Oral Presentation (In-person)
Sara Sentre Domingo, CerTest Biotec, Spain

Background Malaria (or paludism), is a mosquito-borne parasitic disease caused by Plasmodium, is a leading cause of death and disease in many developing countries. The objective of this study was to determine the clinical performance of VIASURE Malaria Real Time PCR Detection Ki [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Meccar Moniem H. Elino
Oral Presentation (In-person)
Meccar Moniem H. Elino, Southern Philippines Medical Center, Philippines

Background: Various diagnostic tests across COVID-19 literatures were employed as surrogate markers in COVID-19, wherein interleukin-6 (IL-6) – gauge for cytokine storm or impending severity – is not readily available among the third world countries particularly the P [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Mark Leoven O. Lumalang
Oral Presentation (In-person)
Mark Leoven O. Lumalang, Adventist Medical Center Manila, Philippines

Background: The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS Cov-2) is a major global public health and socioeconomic crisis. Patients may present with mild symptoms to severe respiratory distress causing major impact in morbidity and mortality. While treat [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Maria Luisa R. Maranan
Oral Presentation (In-person)
Maria Luisa R. Maranan, San Lazaro Hospital, Philippines

Introduction: The Philippines is one of the countries with the fastest rising growth rate of HIV in the Asia Pacific. HIV, HBV and HCV have similarities in terms of risk factors and transmission routes, hence co-infection with HBV and/or HCV are said to be common in HIV-positive [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Philip John Joves
Oral Presentation (In-person)
Philip John Joves, Adventist Medical Center Manila, Philippines

Background: Adherence to antiretroviral therapy (ART) reduces morbidity and mortality among people living with HIV (PLHIV) by suppression of viral replication, restoration and preservation of immune function. However, poor adherence with ART may lead to treatment failure and dea [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Sebar Sala
Oral Presentation (In-person)
Sebar Sala, Zamboanga City Medical Center, Philippines

Background: The increasing prevalence of infections due to Antimicrobial Resistance (AMR) constitutes a serious threat to healthcare systems. This study investigated the trends and compliance to antimicrobial prescribing to identify potential areas for quality improvement. Met [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ernan N. Baluis
Oral Presentation (In-person)
Ernan N. Baluis, Adventist Medical Center Manila, Philippines

Background: In COVID-19 a dysregulated immune response and cytokine storm is the underlying mechanism that determines the adverse outcome. The Neutrophil/Lymphocyte Ratio(NLR) and Platelet/Lymphocyte Ratio(PLR) have been considered as systemic inflammatory response markers. O [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Hideliz Marie G Pascua
Oral Presentation (In-person)
Hideliz Marie G Pascua, Baguio General Hospital and Medical Center, Philippines

Candida duobushaemulonii is a yeast that belongs to the Candida haemulonii species complex. Similar to Candida auris which is an emerging global health threat, C. duobushaemulonii is a major concern in the healthcare system as it is often multidrug resistant. Prese [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Helen Jane Polido
Oral Presentation (In-person)
Helen Jane Polido, Baguio General Hospital and Medical Center, Philippines

Introduction Coronavirus disease 2019 (COVID-19) caused by the virus SARS-CoV-2 is an ongoing global pandemic which led to loss of human life worldwide and presents an unprecedented challenge not only to public health but also to the food systems and the world of work.1 In the P [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Roxanne M Figueroa
Oral Presentation (In-person)
Roxanne M Figueroa, Baguio General Hospital and Medical center, Philippines

Rhabdomyolysis is a life-threatening disorder that manifests with myalgia, fatigue, and pigmenturia, with a mortality rate as high as 59%. Acute renal failure which occurs in 13-50% of cases. Myalgia and fatigue are common constitutional symptoms in patients with viral infection [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Anna Mayleen A. Fermin
Oral Presentation (In-person)
Anna Mayleen A. Fermin, Adventist Medical Center - Manila , Philippines

Background: The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS Cov-2) is a major global public health and socioeconomic crisis. Patients may present with mild symptoms to severe respiratory distress causing major impact in morbidity and mortality. While treat [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Jeng How Yang
Oral Presentation (In-person)
Jeng How Yang, New Taipei Municipal TuCheng Hospital, Taiwan

Background: Cryptococcal meningitis (CM) is associated with high mortality. The relation between antifungal susceptibility and treatment outcomes is not well characterized. There is paucity of surveillance data of cerebrospinal fluid (CSF) isolates of cryptococcus investigated wi [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Gyaltsen Dakpa
Oral Presentation (In-person)
Gyaltsen Dakpa, National Chung-Hsing University, Taiwan

A change in metabolism is one of the hallmarks of coronavirus disease 2019 (COVID-19) that cause severity and mortality. The mechanism of SARS-CoV-2 spike protein-mediated perturbations of metabolic pathways and modulation of antcin A, a steroid-like compound isolated from Taiwan [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Selmi Rachid
Oral Presentation (In-person)
Selmi Rachid, General Directorate of Military Health, Tunisia

Livestock constitute habitual hosts and carriers for several infectious pathogens which may represent a serious public health concern and lead to a wide economic losses. Camels are increasingly the subject of several scientific investigations, showing that they are receptive and [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Darine Slama
Oral Presentation (In-person)
Darine Slama, University of Monastir, Tunisia

The Mermithid nematode parasitizes many biting midges worldwide, causing changes in different parts of their body, especially intersexes phenomena. In Tunisia, and to our knowledge any study was recorded to know if this phenomenon exists and to identify the nematode species invol [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Kenfack Josiane
Oral Presentation (In-person)
Kenfack Josiane, University of YaoundeI-Cameroon, Cameroon

Background: Women of childbearing age are commonly affected by bacterial vaginosis (BV). Maternal-fetal outcomes associated with BV during pregnancy can be fatal for both the mother and the newborn. In this review, we aim to identify maternal and fetal outcomes in pregnant women [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Adela Ngwewondo
Oral Presentation (In-person)
Adela Ngwewondo, Institute of Medical Research and Medicinal Plants Studies, Cameroon

Twenty diseases are recognized as neglected tropical diseases (NTDs) by World Health Assembly resolutions, including human filarial diseases. The end of NTDs is embedded within the Sustainable Development Goals for 2030, under target 3.3. Onchocerciasis afflicts approximately 20. [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Matabou Tene Sosthene Hiillary
Oral Presentation (In-person)
Matabou Tene Sosthene Hiillary, Centre for Research on Emerging and Reemerging Diseases, Cameroon

BACKGROUND: Coronavirus disease 2019 (COVID-19) is an acute, highly transmissible infectious disease. SARS-CoV-2 is the causative agent and is associated with a cytokine storm characterized by increased plasma concentrations of IL-2, 6, and 10. INF-α2 has been reported to [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Mbida Mbida Jean Arthur
Oral Presentation (In-person)
Mbida Mbida Jean Arthur, university of douala, Cameroon

A survey on Human African Trypanosomiasis (HAT) is essential for prevention and preparedness for epidemics. The objective of the study was to assess the circulation of human trypanosomes and their vectors across quiescent HAT foci of the Littoral Region of Cameroon. A descript [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Seumko o Ndeumou Medouen Reine
Oral Presentation (In-person)
Seumko o Ndeumou Medouen Reine, University of YaoundeI-Cameroon, Cameroon

Background: The COVID-19 Pandemic still causes significant morbidity and mortality worldwide. Significantly more cases of COVID-19 and its related deaths are reported in High-Income countries compared to Low- and Middle-Income Countries (LMIC). This might be due to pre-exist [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Saleh Binmahfooz
Oral Presentation (In-person)
Saleh Binmahfooz, King Abdulaziz University, Saudi Arabia

Introduction: Coronavirus disease 2019 (COVID-19) has become the most devastating public health issue in the entire world. The disease has been spreading internationally and has swept the world in a short period. It stated as a pandemic by the World Health Organization on March [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Pradeep Kumar
Oral Presentation (In-person)
Pradeep Kumar, AII India Institute of Medical Sciences, India

Background and aims: Ischemic stroke (IS) causes significant mortality worldwide and has higher incidence among men than women. In this study, we investigated the risk-association of endogenous sex hormones in males and females with ischemic stroke. Methods: Comprehensive lite [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Preetha G S
Oral Presentation (In-person)
Preetha G S, International Institute of Health Management Research, India

Integrated health campaigns with multiple interventions can potentially lead to improved population coverage, service delivery, quality assurance and time efficiencies. We conducted a study in Uttar Pradesh where disease control campaigns are held routinely to achieve national he [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ram Kumar Mahato
Oral Presentation (In-person)
Ram Kumar Mahato, Epidemiology and Disease Control Division, Nepal

Background Nepal has achieved and sustained elimination of leprosy as a public health problem since 2009, but 17 districts and 3 provinces have yet to eliminate the disease. Pediatric cases and grade-2 disabilities (G2D) indicate recent transmission and late diagnosis respectiv [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Bidhi Dhital
Oral Presentation (In-person)
Bidhi Dhital, Charak Memorial Hospital Pvt. Ltd, Nepal

Acute encephalitis syndrome (AES) is defined as acute onset of fever and a change in mental status (including symptoms such as confusion, disorientation, coma or inability to talk) and/or new onset of seizures (excluding simple febrile seizures) in a person of any age at any time [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Zimasa Busisiwe Dubeni
Oral Presentation (In-person)
Zimasa Busisiwe Dubeni, University of Fort Hare, South Africa

Moringaceae, one of the most prominent plant families, includes species with high economic, ecological, and medicinal importance because of their potent phytochemicals. M. oleifera, commonly known as Horse radish is a small, fast, growing, evergreen, deciduous tree. It is among t [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Likhona Dingiswayo
Oral Presentation (In-person)
Likhona Dingiswayo, Medical Microbiology, Free State, South Africa

A distinct strain of Klebsiella pneumoniae (K. pneumoniae) referred to as hypervirulent (hvKp) is associated with invasive infections such as invasive pyogenic liver abscess in young and healthy individuals. In South Africa, limited information is known about the prevalence and v [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Bonginkosi Shabangu
Oral Presentation (In-person)
Bonginkosi Shabangu, University of Witwatersrand, South Africa

BACKGROUND: The proposed study will characterise the genomes of multi-drug resistant hospital-acquired invasive Acinetobacter baumannii (A. baumannii) which overwhelmingly contributes to neonatal deaths, particularly in low-middle income countries (LMICs) where the burden of [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Emmanuel Chukwunenye Uttah
Oral Presentation (In-person)
Emmanuel Chukwunenye Uttah, University of Agriculture & Environmental Sciences, Nigeria

This study was aimed at investigating the epidemiology of paragonimiasis in two selected coastal communities in Calabar suburb, namely Akpabuyo and Calabar South. Seven sputum examinations per person were carried out for the presence of Paragonimus uterobilateralis eggs/ova. Poss [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Aws Sami Sulaiman Al-Farsi
Oral Presentation (In-person)
Aws Sami Sulaiman Al-Farsi, Sultan Qaboos University, Oman

Objectives To study the burden, clinical and laboratory features and outcome of Human Parechoviruses (HPeVs) infection among children managed at a tertiary hospital in Oman. Methods: This is a retrospective study of children (< 18 years of age) with molecular proven HPeV in [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Sana Iqbal
Oral Presentation (In-person)
Sana Iqbal, National Institutes of Health, Pakistan

Objective; to demonstrate the antibiotic usage and trends among pediatric patient admitted in tertiary care hospital of rawalpindi Study Design; Analytical cross sectional study Place and Duration of Study: pediatric in patient department of two tertiary care hospitals of R [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Muhammad Fiaz Qamar
Oral Presentation (In-person)
Muhammad Fiaz Qamar, College of Veterinary & Animal Sciences, Jhang, Pakistan

This study was aimed to prepare a frozen bivalent babesial vaccine and evaluate its efficacy in calves. Babesiosis is a tick-borne disease caused by the parasite Babesia, and is a major problem for cattle production. A bivalent vaccine was prepared using two Babesia species, Babe [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Shem Sam
Oral Presentation (In-person)
Shem Sam, Lake Region Economic Bloc, Kenya

Introduction COVID-19 vaccines are administered to protect populations from SARS-CoV-2 infections. Even in case of breakthrough infections, current vaccines protect people against severe outcomes, that is, acute illness, hospitalization, and fatality. Prevention of patients fr [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Bouklata Nada
Oral Presentation (In-person)
Bouklata Nada, National Institut of Hygiene (INH), Morocco

Objectives: Development of pleural form of tuberculosis is still poorly understood, particularly in quite high-endemic countries like Morocco. Genotypic studies may help understanding the transmission routes of Mycobacterium tuberculosis strains in pleural TB patients. Materi [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Nodirjon Ruzimurodov
Oral Presentation (In-person)
Nodirjon Ruzimurodov, Institute of Immunology and human genomics, Uzbekistan

One of the global problems at the moment is the Coronavirus (COVID-19). Everyone already knows all the consequences of COVID-19. In addition, determining the course of the severity of the disease is also an important factor for both the patient and the medical staff. Until now, t [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ssembatya Benard
Oral Presentation (In-person)
Ssembatya Benard, Vijana Na Children Foundation, Uganda

Introduction:  Research shows that young LGBTQ+ community in Mityana City have less access to MHC services and HIV information, testing and support thereby being at a risk of HIV infections. Vijana Na Children Foundation-Uganda (VINACEF) used social media to provide access [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Tedros
Oral Presentation (In-person)
Tedros, Comsats University, Eritrea

Ethiopia is thought to have the most significant livestock population in Africa. The appearance of contagious diseases can excessively hinder economic development .Foot and mouth disease occurs throughout the country, with the highest incidence reported in central Ethiopia. Foot- [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Hossein Mahmoudvand
Oral Presentation (In-person)
Hossein Mahmoudvand, Lorestan University of Medical Sciences, Iran (Islamic Republic of)

The present investigation was designed to study the prevalence of cryptosporidiosis in the colorectal cancer patients compared to the healthy subjects. The present descriptive case-control study was performed on 174 subjects including 87 healthy people and 87 patients with colore [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Batool Sadeghi-Nejad
Oral Presentation (In-person)
Batool Sadeghi-Nejad, Abadan University of Medical Sciences, Iran (Islamic Republic of)

Fungal sinusitis usually is observed in immunocompromised individuals but may be appear in healthy people. Fungal sinusitis is appeared in invasive, non-invasive, allergic and mycetoma (aspergilloma) forms. Originally this disease was a most commonly descried in ketoacidosis poor [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ahmed
Oral Presentation (In-person)
Ahmed, Debre Markos University, Ethiopia

The poor diagnostic and prognostic potential of existing tools potentially hinder the tuberculosis (TB) prevention and control program. Currently, antigen-specific blood-based biomarkers have become alternatives to improve the diagnostic and prognostic challenges related to tuber [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Dawit Gebreegziabiher Hagos
Oral Presentation (In-person)
Dawit Gebreegziabiher Hagos, Mekelle University, Ethiopia

Rapid and accurate visceral leishmaniasis (VL) diagnosis is needed to initiate prompt treatment to reduce morbidity and mortality. Here, we evaluated the performance of loop-mediated isothermal amplification (LAMP) assay for the diagnosis of VL from blood in an endemic area in Et [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Belay Boda
Oral Presentation (In-person)
Belay Boda, Arba Minch University, Ethiopia

Background: High TB mortality is increasingly understood as an indicator of different problems in the health system and community. Limited awareness of TB in the community, restricted accessibility and/or quality of health services can hamper survival. Exploration and analysis of [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Binega
Oral Presentation (In-person)
Binega, Mekelle University, Ethiopia

Leishmaniasis is one of the most neglected tropical diseases (NTDs), caused by a parasite of the genus Leishmania which is transmitted through a sand-fly vector and mostly affects the poorest of the poor. It is characterized by physiological and clinical manifestations of lesions [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Nataliia Liakhovska
Oral Presentation (In-person)
Nataliia Liakhovska, Poltava State Medical University, Ukraine

Many historical epidemics have been associated with natural or manmade disasters. Military events cause the spread of infections. This has been known for thousands of years. There are many scientific papers that emphasize the need for early action on the center of possible spread [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Nitosh Kumar Brahma
Oral Presentation (In-person)
Nitosh Kumar Brahma, IEI(The Institution of Engineers, India), IGE(The Institute of Genetic Engineering), India

Mutational variation of COVID-19 and the prophylaxis of its infective mode corona to human are climate dependent. The said molecular biological problem could be explained in following manner. It is proposed that transcription aspects of corona are genetic dependent and ACE is the [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Nitosh Kumar Brahma
Oral Presentation (In-person)
Nitosh Kumar Brahma, IEI(The Institution of Engineers, India), IGE(The Institute of Genetic Engineering), India

Virulence factors of pathogenic bacteria (adhesins, toxins, invasions, protein secretion systems, iron uptake systems, and others) may be encoded by particular, regions of the prokaryotic genome as pathogenicity islands of Escherichia coli, at 10–200, kilobases (kb) G+C con [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Abidemi Nurat Akinbami
Oral Presentation (In-person)
Abidemi Nurat Akinbami, University of Ibadan, Nigeria

Background Vulvovaginal candidiasis (VVC) is a fungal infection of the female lower genital tract - the vulva and the vagina, caused by Candida species. Vulvovaginal candidiasis has the following therapeutic challenges; limited number of effective antifungal agenthe ts, toxicity [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ines Chalbaoui
Oral Presentation (In-person)
Ines Chalbaoui, Mohamed Kassab Institute of Orthopedics, Tunisia

Introduction : Early osteoarticular material infection is becoming more common these days. It requires complex and multidisciplinary management. The objective is to study the clinical, diagnostic, and therapeutic particularities of early osteoarticular material infection. Mat [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Aladejana Oluwatoyin Modupe
Oral Presentation (In-person)
Aladejana Oluwatoyin Modupe, Redeemers University, Nigeria

Bats (Chiroptera) are taxonomically and ecologically diverse group of animals found in almost all habitats and trophic levels. There are over 1,300 species of bats documented worldwide. Nigeria supports almost a third of the bat diversity known in Africa.  Bat is commonly as [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Monireh Khordadmehr
Oral Presentation (In-person)
Monireh Khordadmehr, University of Tabriz, Iran (Islamic Republic of)

Microsporidia, are unicellular and obligate intracellular eukaryotes considered as emerging opportunistic human and animal pathogens. To determine microsporidiosis in domestic pigeons in Iran privately-owned pigeons (n=100) presenting weight loss and diarrhea were tested for micr [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Josephine Kagunda
Oral Presentation (In-person)
Josephine Kagunda, University of Nairobi, Kenya

Malaria prevalence in sub-Saharan Africa remains high. Kenya for example, recordsabout 3.5 million new cases and 11 thousand deaths each year.1 Most of these cases and deaths are among children under five. The main control method in malaria endemic regions has been through the us [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Khudoydotov Yodgor
Oral Presentation (In-person)
Khudoydotov Yodgor, Tashkent medical academy, Uzbekistan

Objective: One of the most frequent non-motor manifestations of parkinson (PD) - pain. The frequency of chronic pain in PD lasting more than three months, according to different authors, is from 40 to 70% and exceeds it in general population from 20 to 44%. Assume pain in patient [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Saiema Ahmedi
Oral Presentation (In-person)
Saiema Ahmedi, Jamia Millia Islamia, India

A major global problem is the severe toxicity of conventional antifungal medications and multidrug resistance. Investigation of new substances with outstanding therapeutic potential is necessary. In this work, the antifungal potential of limonene, a secondary metabolite present i [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Norana Abdul Rahman
Oral Presentation (In-person)
Norana Abdul Rahman, Perdana University Malaysia, United Kingdom

Introduction: Leprosy, or Hansen's disease, is a chronic infectious disease caused by a bacillus, Mycobacterium leprae. The infection has a long incubation period, primarily affecting the skin, mucous membranes, and peripheral nerves. Leprosy is curable with multidrug th [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Satyendra SIngh
Oral Presentation (In-person)
Satyendra SIngh, Central University of Rajasthan, India

Background: The most recent monkeypox outbreak began in April of 2022, and the initial confirmed case was reported on May 7. The disease then spread to 70 non-endemic countries in less than 15 days, prompting the World Health Organization to declare monkeypox a public health emer [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Varshita Srivastava
Oral Presentation (In-person)
Varshita Srivastava, Central University of Rajasthan, India

According to the Center for Disease Control and Prevention, as of August 23, 94 countries had confirmed 42,954 Monkeypox Virus cases. As specific monkeypox drugs are not yet developed, the treatment depends on repurposed FDA-approved drugs. According to a recent study, the Monkey [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Debmalya Mitra
Oral Presentation (In-person)
Debmalya Mitra, ICMR National Institute of Cholera and Enteric Diseases, India

Colitis is a multifaceted disease which is a global threat in the present times. It is hypothesised that novel prebiotics like Gum Odina (GO) are emerging as preventive therapy to combat chronic gut diseases due to their ease of incorporation into diet and established health bene [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Klemen Bohinc
Oral Presentation (In-person)
Klemen Bohinc, Faculty of Health Sciences, Slovenia

The application of orthopedic implants in our body is associated with the possibility of infection. To have the infections under control interactions between microorganisms and implant surfaces needs to be understood. Therefore, in this presentation we consider the microbial adhe [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Kushal Kalvit
Oral Presentation (In-person)
Kushal Kalvit, Tata Memorial Hospital, India

Introduction NORSE is an umbrella term with different aetiologies. The usual suspects are structural lesions, infections, toxins, metabolic causes, autoimmune or paraneoplastic encephalitis. Measles is a common infection that presents with a rash and is typically self-limiting. [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Shivanand
Oral Presentation (In-person)
Shivanand, Kalasalingam Academy of Research and Education, India

Background: In India, a collective range of measurement had been adopted to control the massive spread of the COVID-19 pandemic. Such overall population could significantly influence knowledge, attitude and practice (KAP) towards COVID-19. Field survey-based study was conducted [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ugochukwu Clement Chukwunenye
Oral Presentation (In-person)
Ugochukwu Clement Chukwunenye, Medecins San Frontieres, Nigeria

Background: Lassa fever is a viral haemorrhagic disease endemic in West Africa. Between 300,000 to 500,000 people get infected annually, with nearly 5000 deaths. In the last five years, several programs and interventions were employed in Ebonyi State to prevent and manage Lassa f [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Susan Jack
Oral Presentation (In-person)
Susan Jack, University of Otago, New Zealand

Invasive meningococcal disease is a severe disease caused by Neisseria meningitidis that can present as septicaemia or meningitis and may lead to disability or death.  Nasopharyngeal carriage of N. meningitidis may occur in up to 15% of the general population with a higher p [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Pradeep Kumar
Oral Presentation (In-person)
Pradeep Kumar, AII India Institute of Medical Sciences, India

Our systematic review and meta-analysis of the association between intake of vitamins A, B12, C, D, and E and the risk of stroke indicate that higher vitamin B12 intake may be associated with a reduced risk of stroke, while the effect of vitamin C on stroke risk is uncertain. No [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Susan M Dallabrida
Poster Presentation (In-person)
Susan M Dallabrida, SPRIM US LLC, United States

Objective: COVID-19, caused by a coronavirus, SARS-CoV-2, has been the cause of the global pandemic from 2020-2022. Due to COVID-19’s novelty, there exist no validated patient reported outcome (PRO) tools that allow for proper evaluation of patient infection severity based [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Hertel Quentin
Poster Presentation (In-person)
Hertel Quentin, University of Montpellier, France

The alarmin S100A9 is a calcium-binding protein known for its pro-inflammatory extracellular role in the immune response against pathogens in the form of a S100A8/S100A9 heterodimer called calprotectin. However, S100A9 was recently shown to exert an intracellular antiviral effect [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Elisabetta Di Felice
Poster Presentation (In-person)
Elisabetta Di Felice, Experimental Zooprophylactic Institute of Abruzzo and Molise Giuseppe Caporale, Italy

Lumpy skin disease (LSD) is a viral disease of cattle and water buffalo characterized by cutaneous nodules, biphasic fever, oral and nasal discharge, accompanied by general lymphadenitis. Clinical infections in cattle range from sub-clinical to acute form and the disease is assoc [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Tania Audino
Poster Presentation (In-person)
Tania Audino, Istituto Zooprofilattico Sperimentale di Piemonte, Italy

Due to marine mammals’ demonstrated susceptibility to SARS-CoV-2, based upon the homology level of their angiotensin-converting enzyme 2 (ACE2) viral receptor with the human one, alongside the global SARS-CoV-2 occurrence and faecal contamination of the river and marine eco [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Josh Nathan L. Ngai
Poster Presentation (In-person)
Josh Nathan L. Ngai, St. Luke's Medical Center, Philippines

Introduction: Febrile neutropenia is a major cause of morbidity and mortality in children with hematologic malignancies. It presents as a serious, potentially fatal condition complicating cancer treatment associated with significant morbidity and mortality. To date, established n [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Emelia Katrina I. Cafugauan
Poster Presentation (In-person)
Emelia Katrina I. Cafugauan, St. Lukes Medical Center, Philippines

Reluctance to COVID 19 vaccination that is secondary to limited knowledge on side effects, reporting of serious adverse reactions and emergency use of the vaccine is a major problem that could hinder achieving herd immunity against COVID 19 infection. Continuous monitoring and re [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Maria Luz Isadora L. Timbancaya
Poster Presentation (In-person)
Maria Luz Isadora L. Timbancaya, St. Luke’s Medical Center, Philippines

Background. The gold standard in the diagnosis of COVID-19 infection remains to be through RT-PCR. This is done through the determination of a cycle threshold value. There have been conflicting studies as to whether the cycle threshold value can also be used to determine disease [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Patricia Abigail B. Miranda
Poster Presentation (In-person)
Patricia Abigail B. Miranda, St. Luke’s Medical Center, Philippines

COVID-19 infection is a novel viral illness which began as a local epidemic in December 2019 at Wuhan, China which quickly emerged into a pandemic by February 2020. The virus causes a spectrum of signs and symptoms, ranging from mild upper respiratory symptoms to acute respirator [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Pardis Riahi
Poster Presentation (In-person)
Pardis Riahi, University of Toronto, Canada

Lyme disease is caused by spirochete members of the Borrelia burgdorferi (B. burgdorferi) sensu lato species complex and is transmitted by Ixodes ticks (Stanek et al., 2012). Hematogenous (blood-borne/vascular) dissemination is critical for the spread of B. burgdorferi from the i [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Kristina Cerniauskiene
Poster Presentation (In-person)
Kristina Cerniauskiene, Lithuanian University of Health Science, Lithuania

Introduction: Acinetobacter baumannii (A. baumannii) is an important nosocomial pathogen that possesses not only intrinsic resistance to many classes of antibiotics, but also has a propensity for rapid development of antimicrobial resistance during treatment. Aims & O [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Milda Pleckaityte
Poster Presentation (In-person)
Milda Pleckaityte, Vilnius University, Lithuania

The incidence of invasive meningococcal disease (IMD) in Lithuania was among the highest in Europe during the past two decades reaching an average of 2.24 cases/100,000 population. The vast majority of IMD cases were caused by serogroup B meningococci. In 2018, the only four-comp [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Aurelija Žvirbliene
Poster Presentation (In-person)
Aurelija Žvirbliene, Vilnius University, Lithuania

Neisseria meningitidis causes invasive meningococcal disease (IMD), which is associated with significant mortality and long-term consequences, especially among young children. The incidence of IMD in Lithuania was among the highest in European countries during the past two decade [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Kathrin Weyer
Poster Presentation (In-person)
Kathrin Weyer, Heel GmbH, Germany

Despite the introduction of vaccines and new anti-viral therapies, the COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be a serious global public health crisis. The emergence of new viral variants that escape protection from [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Juanita Leon
Poster Presentation (In-person)
Juanita Leon, Cancer Research and Treatment Center Luis Carlos Sarmiento Angulo, Colombia

Invasive mycoses are linked to higher mortality and morbidity (1). Most of these infections are hospital acquired, frequent in intensive care units and account approximately for 15% of healthcare related infections (1, 2). The aim of this paper is to analyse available data on hea [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Jairo Cardenas
Poster Presentation (In-person)
Jairo Cardenas, Hospital Regional de Moniquira, Colombia

Introduction: Moniquira is a small town in Colombia, with 20,800 inhabitants. The main economic activity is agriculture. Leptospirosis is a zoonotic disease related with contaminated water, animals, and poverty. The aim of this paper is to describe the clinical course of the dise [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Houda Limam
Poster Presentation (In-person)
Houda Limam, Faculty of Medicine of Tunis, Tunisia

Pseudomonas aeruginosa is an opportunistic pathogen, commonly causing hospital-acquired infections in burn patients. P. aeruginosa with difficult-to-treat resistance (DTR-PA) is resistant to all of the following: piperacillin-tazobactam, ceftazidime, cefepime, aztreonam, meropene [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Mohsin Khared
Poster Presentation (In-person)
Mohsin Khared, King Abdulaziz University, Saudi Arabia

Surgical site infections (SSI) are a significant cause of morbidity and mortality after surgery. Due to its high morbidity and mortality rates after open-heart surgery, sternal wound infection (SWI) is one of the most important consequences to avoid and manage. Staphylococcus spe [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Yuying Tang
Poster Presentation (In-person)
Yuying Tang, Southeast University, China

Purpose : Dendritic cells (DCs) are always known as professional APCs which play a crucial role  in the link between innate and adaptive immunity. DCs can initiate both immunity and immunological tolerance , which means efficacy either in amelioration or exaggeration of infl [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Uzma Saqib
Poster Presentation (In-person)
Uzma Saqib, DAVV academic University, India

Toll/interleukin-1 like receptors (TLRs) are membrane-spanning proteins crucially involved in innate immunity. On activation, the cytoplasmic toll/interleukin-1 receptor (TIR) domains of these receptors undergo homo- or heterodimerization. Brucella sp. are bacterial pathogens tha [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ratna Ayu Cahaya Kusuma Dewi
Poster Presentation (In-person)
Ratna Ayu Cahaya Kusuma Dewi, Diponegoro University, Indonesia

Background Tuberculous (TB) meningoencephalitis is a major global health problem and the most severe form of extrapulmonary TB with high mortality rate. In case Mycobacterium tuberculosis (MTB) is suspected as the etiology, early diagnosis and treatment with anti-tuberculosis dr [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Elfian Rachmawati
Poster Presentation (In-person)
Elfian Rachmawati, Diponegoro University, Indonesia

Leptospirosis co-infection and the pathogenesis of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) play a significant part in the emergence and progression of SARS-CoV-2 infection by enhancing the difficulty of identification, management, and outcome of COVID-19 well [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Marwah Saud Al-Thuhli
Poster Presentation (In-person)
Marwah Saud Al-Thuhli, Oman Medical specialty Board, Oman

Objectives: Bloodstream infection (BSI) in children causes significant morbidity and mortality and is associated with longer hospital stays and higher healthcare costs. Our objective is to study the incidence and risk factors and identify causative organisms and outcomes of BSI a [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Nidhal Al Harrasi
Poster Presentation (In-person)
Nidhal Al Harrasi, Oman Medical Specialty Board, Oman

Background: Acute meningitis is an inflammation of the tissue surrounding the brain, commonly caused by viruses and bacteria. The typical clinical manifestations of acute meningitis include fever, headache, neck stiffness and change in mental status 5,8. The diagnosis is made by [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Yarmuhamedova Nargiza
Poster Presentation (In-person)
Yarmuhamedova Nargiza, Samarkand State Medical University, Uzbekistan

The problems of infections transmitted by sucking a tick are due to the expansion of the distribution area of ticks and an increase in the incidence of tick-borne infections. Farm animals that make up the agrobiodiversity of Uzbekistan are at risk of disease with numerous pathoge [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Devanshi Sharma
Poster Presentation (In-person)
Devanshi Sharma, Hamdard Institute of Medical Science and Research, India

Background: CoNS, a major commensal of skin, now a notable cause of nosocomial infections, especially in patients undergoing surgical procedures. In previous decades, the β-lactams, most efficient weapons to control CoNS infection, have now blunted progressively. CoNS have [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Dumisile Sibongile Nkosi
Poster Presentation (In-person)
Dumisile Sibongile Nkosi, University of Siena, Malawi

Background Malawi's 28 districts saw a rise in DPT3 coverage from 84% to 94% between 2016 and 2020, however, only 78% of the districts achieved >80% coverage. This indicates that there is still a gap in childhood vaccine coverage within the country. Objectives The ma [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Chansay Pathammavong
Poster Presentation (In-person)
Chansay Pathammavong, National Immunization Program, Lao, People's Democratic Republic

Objective: To eliminate measles and rubella, it is critical to develop strategic and efficient immunization programs. This study aimed to evaluate the population immunity and the measles-rubella program's effectiveness by estimating anti-measles and anti-rubella IgG prevalenc [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ivelina Trifonova Trionova
Poster Presentation (In-person)
Ivelina Trifonova Trionova, National Centre of Infectious and Parasitic Diseases, Bulgaria

After a period of two seasons of absence (2020/2021) or low prevalence (2021/2022) of influenza viruses, the 2022-2023 season was characterized by high influenza activity in Bulgaria. The objectives of this study were to analyze the pattern of influenza virus circulation with res [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Viacheslav Viktorovich Sushko
Poster Presentation (In-person)
Viacheslav Viktorovich Sushko, National University “Odessa Law Academy”, Ukraine

Introduction In Odessa, the police detained three people who thought they were sick COVID-19 and tried to infect others intentionally spit on the front door handles, on the handles of cars parked near shops, on the railing in the entrances of multi-storey buildings.  This w [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Joel Vourchakbe
Poster Presentation (In-person)
Joel Vourchakbe, Research professor at the University of Doba, Chad

Human African trypanosomiasis (HAT) has been targeted for zero transmission to humans by 2030. Animal reservoirs of gambiense-HAT could jeopardize these elimination goals. This study was undertaken to identify potential host reservoirs for Trypanosoma brucei gambiense by detectin [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Kirga Kabo Abakar
Poster Presentation (In-person)
Kirga Kabo Abakar, Catholic University of Central Africa, Chad

Antimicrobial surveillance and identification of the genetic basis of antimicrobial resistance provides important information to optimize patient care. The present study was an analytical crosssectional study aimed at determining the prevalence of rifampicin and ofloxacin resista [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Jacob Maihondoum
Poster Presentation (In-person)
Jacob Maihondoum, Universite de Yaounde I, Chad

The present reflection starts from an alarming observation of the epidemiological situation of Guinea worm disease in rural Chad despite institutional mobilizations. In 2010, 16 cases were reported in humans and more than 1000 dogs were infected in 2016. The number of infections [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ali Mirzapour
Poster Presentation (In-person)
Ali Mirzapour, Islamic Azad University, Iran (Islamic Republic of)

Background: Cats as the definitive hosts of Toxoplasma gondii play an important role in parasite dispersion and outbreaks. To understand the transmission pattern of this parasite, the distribution of genetic diversity of T. gondii in cats is important. The current study aimed to [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ali Mirzapour
Poster Presentation (In-person)
Ali Mirzapour, Islamic Azad University, Iran (Islamic Republic of)

Abstract: Toxascaris leonina is an ascaridoid nematode of dogs and cats; this parasite afects the health of these animals. This study estimated the global prevalence of Ta. leonina infection in dogs and Cats using random efects meta-analysis as well as subgroup, meta-regression a [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Yuefeng Song
Poster Presentation (In-person)
Yuefeng Song, Medical School of Nanjing University, China

Objective: To analyze the correlation between serological test results and oral clinical manifestations of patients with secondary syphilis, and to provide reference for clinical diagnosis and treatment. Methods: From January 2016 to December 2020, 30 patients with secondary [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Bakhytkul Zhakipbayeva
Poster Presentation (In-person)
Bakhytkul Zhakipbayeva, Medical Epidemiologist CDC Central Asia, Kazakhstan

Introduction. Acute meningitis and encephalitis (AME) is a neurological inflammation associated with substantial morbidity and mortality caused by different pathogens. In Kazakhstan, comprehensive testing to identify viral causal pathogens is not routinely performed. Additionall [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Wenmei Wang
Poster Presentation (In-person)
Wenmei Wang, Medical School of Nanjing University, China

Objective: To evaluate the effect of a new anti-splash mask on preventing aerosol pollution in dental clinics. Methods: The aerosol distribution characteristics in different types of splash operations were analyzed in dental clinics at first. Different splash operations were [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - G.Garbouj
Poster Presentation (In-person)
G.Garbouj, Infectious Diseases Department Kassab Institute of Orthopedics, Tunisia

Introduction: Secondary infection of eschar in paraplegic patients is a common but serious complication. It increases the burden of care for these patients and puts them at risk of death. The objective of our study was to describe the epidemiological, clinical, and therapeutic ch [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Shayma Hamza
Poster Presentation (In-person)
Shayma Hamza, kassab institute of orthopedics, Tunisia

Introduction: One of the major complications of spinal cord injury is the neurologic bladder that no longer empties autonomously. Urinary tract infection (UTI) is a major cause of morbidity and mortality in these patients, and the objective of our study was to describe the clinic [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Houda Limam
Poster Presentation (In-person)
Houda Limam, Faculty of Medicine of Tunis, Tunisia

Background : Brucellosis is a common bacterial zoonotic disease with a broad spectrum of clinical manifestations. Osteoarticular involvement is frequent, with a reported prevalence ranging from 27% in nonendemic regions to 36% in endemic regions. The sacroiliac and spinal joints [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Mairie Guizaw Kebede
Poster Presentation (In-person)
Mairie Guizaw Kebede, Saint George dermatology clinic, Ethiopia

Background: Leishmania aethiopica is a peculiar parasite causing cutaneous leishmaniasis in Ethiopia and its mainstay treatment is Sodium Stibogluconate. However its treatment outcome in Ethiopia is not well documented. Objectives:  To determine the treatment outcome of a [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Elena Hatalova
Poster Presentation (In-person)
Elena Hatalova, Pavol Jozef Safarik University, Slovakia (Slovak Republic)

Blastocystis spp., Cryptosporidium spp., Giardia intestinalis and Microsporidia spp. are protozoan and fungal intestinal pathogens in immunocompromised individuals, causing symptomatic or asymptomatic infections, which are usually undiagnosed. Uremia in hemodialysis patients with [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Preeti Chaudhary
Poster Presentation (In-person)
Preeti Chaudhary, ICMR-National Institute of Malaria Research, India

Malaria remains a global health issue affecting half of the world's population. The current treatment regimen which includes artemisinin and other combination therapies is being threatened with the rapid emergence of resistance. P. falciparum under drug pressure has revealed [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Rege Anna Marton
Poster Presentation (In-person)
Rege Anna Marton, University of Veterinary Medicine, Hungary

The indiscriminate use of conventional antibiotics has contributed to the global spread of antibiotic resistance, therefore, there is an urgent demand to search for alternatives that can provide a novel antimicrobial mode of action. Finding a potential replacement is crucial for [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Magdalena Piatek
Poster Presentation (In-person)
Magdalena Piatek, Maynooth University, Ireland

The antimicrobial activity of silver has long been established and is widely used clinically. The low toxicity and broad-spectrum activity of silver make it a promising candidate in the fight against resistant pathogens. N-heterocyclic carbenes (NHCs) constitute a versatile range [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Tafaani Khan
Poster Presentation (In-person)
Tafaani Khan, Department of Pediatric Infectious Diseases at Boston Medical Center , United States

The Nasopharyngeal Surveillance Study clinically investigates the progression of Streptococcus pneumoniae (SP) nasopharynx (NP) colonization in relation to the Pneumococcal Conjugate Vaccines, specifically 7-Valent Pneumococcal Conjugate Vaccine, 13-Valent Pneumococcal Conjugate [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Zsaklin Varga
Poster Presentation (In-person)
Zsaklin Varga, University of Pecs, Hungary

The mosquito-borne pathogens are present worldwide, notable among these are Dirofilaria immitis, which causes heartworm disease, and Dirofilaria repens, known as the causative agent of subcutaneous dirofilariasis. These two species are unfortunately endemic throughout Europe and [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Alaaeldeen Balal Ahmed
Poster Presentation (In-person)
Alaaeldeen Balal Ahmed, Omdurman Islamic University, Sudan

Background: Rotavirus infection is the most common cause of severe diarrhea in young children and infants worldwide. Epidemiological knowledge concerning rotaviruses among infants and children is critical for the development of effective measures, including vaccines. Meth [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Sheema Mir
Poster Presentation (In-person)
Sheema Mir, Western University of Health Sciences, United States

The infectious disease diagnostics often depends on costly serological testing with poor sensitivity, low specificity, and long turnaround time. Here In this manuscript, we demonstrate the proof of the principle for simultaneous detection of two tickborne pathogens from a single [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ranjan Ramasamy
Keynote Presentation (Virtual)
Ranjan Ramasamy, IDFISH Technology, United States

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious RNA virus that was first identified in December 2019 in Wuhan, China. It is the pathogen responsible for the present coronavirus disease 2019 (COVID-19) pandemic. A large number of genetic var [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Alfredo Berzal-Herranz
Keynote Presentation (Virtual)
Alfredo Berzal-Herranz, Instituto de Parasitologia y Biomedicina “Lopez-Neyra”, (IPBLN) CSIC, Spain

RNA viruses are a major threat to the human health. They are responsible for infections with high morbidity and mortality rates and an extraordinary socioeconomic burden. In the last decades, different RNA viruses have produced major outbreaks against which there were no efficien [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Chunyang Li
Keynote Presentation (Virtual)
Chunyang Li, Jiangsu Academy of Agricultural Sciences, China

Infectious diseases are becoming a health burden, causing numerous hospitalisation cases and deaths and leading to global economic losses. The prevention and control of infectious diseases have become more important as a result of the COVID-19 pandemic. Traditional disinfection m [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Masafumi Seki
Keynote Presentation (Virtual)
Masafumi Seki, Saitama Medical University International Medical Center, Japan

Background: New antiviral agents for COVID-19, including molnupiravir for the oral treatment and sotrovimab as the monoclonal antibody for the intravenous treatment are currently authorized and available in addition to remdesivir for the intravenous treatment in Japan. Method [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Chin Kim Ling
Oral Presentation
Chin Kim Ling, Institute for Advanced Studies, Universiti Malaya, Malaysia

Neonatal microcephaly and adult Guillain-Barré syndrome are severe complications of Zika virus (ZIKV) infection. The robustly induced inflammatory cytokine expressions in ZIKV-infected patients may constitute a hallmark for severe disease. One of them is the high mobility [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Kaila Petronila Medina Alarcon
Oral Presentation
Kaila Petronila Medina Alarcon, Universidade Estadual Paulista (UNESP), Peru

Polymicrobial biofilms are associated with a wide range of infections, present in medical devices such as catheters and joint prostheses, valves, and in chronic tissue infections, which occur mainly in patients with cystic fibrosis, and oral infections, among others, as well as o [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Aime Christian Kayath
Oral Presentation
Aime Christian Kayath, Universite Marien Ngouabi, Congo

In order to contribute to the understanding of the mechanism of invasion of epithelial cells by Shigella sp., we have first shown (i) Shigella strains as well as clinical or environmental strains are able to secrete biosurfactant-like molecules (BLM) directly [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Nahed Seddiq
Oral Presentation
Nahed Seddiq, BDF RMS, Bahrain

With all the advances in medicine and medical treatments, MDR bacteria remains one of the greatest threats in healthcare systems. The rates of AMR (antimicrobial resistance) organisms continues to increase globally despite the efforts to combat. WHO has declared that AMR is one o [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Elmira Ahmadi
Oral Presentation
Elmira Ahmadi, Tarbiat Modares University, Iran (Islamic Republic of)

With the presence of COVID-19 vaccines, the prevalence of new COVID-19 strains is decreasing dramatically. In the meantime, many vaccines were produced, Despite the beneficial effects of the COVID-19 vaccines, their side effects have also been revealed recently. One of the side e [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Maryam Fazeli
Oral Presentation
Maryam Fazeli, Motamed Cancer Institute, Iran (Islamic Republic of)

Background and Purpose: Rabies virus is a fatal infectious disease in the mammalian host including humans, carnivores, and livestock which imposes a huge burden on the health of the community and the global economy. The development of new rabies vaccines is a criti [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - El Hadji Seydou Mbaye
Oral Presentation
El Hadji Seydou Mbaye, International Agency for Research on Cancer/World Health Organization, Senegal

INTRODUCTION: Worldwide, one in eight deaths is due to cancer. Projections based on the GLOBOCAN 2012 estimates predict a substantive increase new cancer cases per year by 2035 in developing countries if preventive measures are not widely applied. According to the World Health Or [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Kevin Cham A. Bueno
Oral Presentation (Virtual)
Kevin Cham A. Bueno, San Lazaro Hospital, Philippines

Background: Multiple therapeutic agents have been demonstrated to provide benefits against COVID-19. Clinical trials which evaluated remdesivir for SARS-CoV-2 infection had shown efficacy in disease recovery and mortality and it is of equal importance to determine the onset of tr [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Maria Yvez Erika P. Ugale
Oral Presentation (Virtual)
Maria Yvez Erika P. Ugale, San Lazaro Hospital, Philippines

Introduction: The SARS-CoV-2 virus, the main causative agent of COVID 19 infection was first detected in the province of Hubei in Wuhan China in December of 2019 and has overwhelmed the capacity of the government and hospitals to provide healthcare services to cater to the growin [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Diana Gonzaga Ramos
Oral Presentation (Virtual)
Diana Gonzaga Ramos, Research Institute for Tropical Medicine, Philippines

Background: The initiation of anti-retroviral therapy (ART) effectively restores immune function and reduces HIV-related morbidity and mortality. However, virologic failure while on ART may lead to increased morbidity and compromised quality of life. The aim of this study was to [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Abegail b. Latawan-danasen
Oral Presentation (Virtual)
Abegail b. Latawan-danasen, San Lazaro Hospital, Philippines

Pulmonary tuberculosis is a worldwide global health burden. According to the WHO guidelines on tuberculosis infection prevention and control that was updated last 2019, tuberculosis accounts for more than 10million cases per year and the deaths caused by Tuberculosis alone accoun [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Rushnol Jade Tupac
Oral Presentation (Virtual)
Rushnol Jade Tupac, Baguio General Hospital and Medical Center, Philippines

Introduction:  Chromoblastomycosis is a chronic subcutaneous fungal infection characterized by the presence of muriform cells commonly diagnosed among countries  in tropical and subtropical regions like Africa, Latin America, India, China, Japan, Malaysia and Austral [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Micaela J.San Diego
Oral Presentation (Virtual)
Micaela J.San Diego, San Lazaro Hospital, Philippines

Introduction: Dengue fever is a significant cause of morbidity throughout the world caused by the dengue virus (DENV). Four antigenically different dengue virus serotypes (DENV-1,2,3, and 4) are known to cause infections in humans (Halsey,2012). Chances for developing dengue hem [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Wilma Cleo Yvonne Dapog
Oral Presentation (Virtual)
Wilma Cleo Yvonne Dapog, Adventist Medical Center Manila, Philippines

Background: Multisystem Inflammatory Syndrome (MIS) is a rare form of COVID-19 affecting multiple extrapulmonary organ systems without severe respiratory illness. It is primarily seen in children under 21 years of age but with similar but rare syndrome in adults that may require [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Janice de Grace L. Tulawie
Oral Presentation (Virtual)
Janice de Grace L. Tulawie, San Lazaro Hospital, Philippines

Introduction: The main causative agent of Tetanus infection is the bacterium Clostridium tetani, a gram-positive, spore-former obligate anaerobic microorganism. It continues to be an important public health concern in developing countries like the Philippines, even though it is p [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Eduardo Alba Mojares
Oral Presentation (Virtual)
Eduardo Alba Mojares, Adventist Medical Center Manila, Philippines

Background: Mortality of tetanus infection is directly proportional to the severity of infection. Tetanus is a preventable yet very fatal disease due to its autonomic dysfunction, muscle spasms, and rigidity. Aggressive intervention is necessary in order to manage the Tetanus in [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Gayatri Tripathi
Oral Presentation (Virtual)
Gayatri Tripathi, ICAR-Central Institute of Fisheries Education, India

Diseases of microbial aetiology of economic significance have surfaced in the aquaculture sector leading to high mortality and economic losses for farmers. Various environmentfriendly remedial measures have been taken up as an alternative to antibiotics to control microbial disea [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Bala Subramani Gattu Linga
Oral Presentation (Virtual)
Bala Subramani Gattu Linga, Jawaharlal Nehru University, India

Short Introduction: Drug repurposing is an alternative avenue for identifying new drugs to treat tuberculosis (TB). Although TB can be cured with anti-tubercular drugs, the emergence of multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculos [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Anu Shanthini
Oral Presentation (Virtual)
Anu Shanthini, Madras Medical College, India

BACKGROUND AND AIM: Tuberculosis is known to mimic several condition, especially malignancy. Pulmonary TB can present with pulmonary infiltration with or without mediastinal lymphadenopathy. TB often gets misdiagnosed in the countries having low incidence of TB with high incidenc [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Georgios D. Theodorakopoulos
Oral Presentation (Virtual)
Georgios D. Theodorakopoulos, BSc (c) RPod, MBA, MSc, BSc RN, PgCert, Greece

The last 2 years after breakout of Covid pandemic there have been reported and published skin integrity complications mostly in critical care departments covid infected patients. International literature highlights the spread per 57% of facial pressure ulcer development, as conse [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Rajaa Sulaiman Al Aamri
Oral Presentation (Virtual)
Rajaa Sulaiman Al Aamri, Ministry of health, Oman

Aim of study: Group B streptococcus (GBS) is a leading cause of invasive infection among neonates and infants worldwide, with two described syndromes, early onset GBS (EOGBS) disease and late onset GBS (LOGBS) disease. In our study, we investigated the incidence of invasive GBS [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Isra Mufadal Abdulkareem
Oral Presentation (Virtual)
Isra Mufadal Abdulkareem, Respiratory medical council, Sudan

Background:  Even though respiratory viruses are one of the most common triggers for asthma exacerbations, not all of these viruses affect patients equally. Objective: To assess the prevalence of covid19 infection in patients presented with acute exacerbation of asthma, C [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Bernsah Damian Lawong
Oral Presentation (Virtual)
Bernsah Damian Lawong, Ahmadu Bello University, Nigeria

Background: Nigeria accounts for 25% of Neglected Tropical Disease (NTDs) burden. The disease tends to impact negatively on wellbeing and productivity. Efforts via health expenditure for NTDs programme have not improved health outcomes. The study examines long-run relationship b [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Wanyana Mercy Wendy
Oral Presentation (Virtual)
Wanyana Mercy Wendy, Uganda National Institute of Public Health, Uganda

Background: Contact tracing (CT) can support Ebola Virus Disease (EVD) outbreak control, but its effectiveness depends on rapid identification and regular, close monitoring of contacts. Ideally, all new cases should be previously-known contacts and spend minimal time ill in the c [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Aboozar Soltani
Oral Presentation (Virtual)
Aboozar Soltani, Shiraz University of Medical Sciences, Iran (Islamic Republic of)

Background: Insects always play an important role in the global ecosystem. Several hypotheses and studies were conducted emphasizing their role in transmitting or spreading the virus in the environment. Among insects, flies are the most common and anthropophilic insects in the w [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Brandon Luck
Oral Presentation (Virtual)
Brandon Luck, Baylor University, United States

Background: Intracranial aneurysms (IAs) are more prevalent in women than men and aneurysmal subarachnoid hemorrhage disproportionately affects postmenopausal women. These sex differences suggest estrogen protects against IA progression that can lead to rupture, but the unde [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Nai An Lai
Oral Presentation (Virtual)
Nai An Lai, Mater Health, Australia

Severe pneumonia is one of the most common causes of sepsis and respiratory failure requiring intensive care. Despite advances in diagnostic techniques, antimicrobial therapy, respiratory support and organ support modalities; mortality and morbidity of severe pneumonia remain sig [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Rigoberto Fimia Duarte
Oral Presentation (Virtual)
Rigoberto Fimia Duarte, University of Medical Sciences of Villa Clara (UMC-VC), Cuba

The objective of the present research consisted in demonstrating the potentialities and real capacity of application of the methodology of the Regressive Objective Regression (ROR) in the different fields and branches of scientific research. The results obtained were possible, th [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Mandy Sze Wee Ng
Oral Presentation (Virtual)
Mandy Sze Wee Ng, Queen Elizabeth II Jubilee Hospital, Australia

Vancomycin has been in clinical use for more than 50 years. It is a highly effective antimicrobial agent against gram positive organisms including methicillin-resistant Staphylococcus aureus and Enterococci spp. However, there are practical challenges in the use of vancomycin inc [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Liaqat Ali
Oral Presentation (Virtual)
Liaqat Ali, National University of Medical Sciences, Pakistan

Since their development, vaccines have dramatically reduced the burden of numerous infectious diseases, promoting individual and social growth, prosperity and wellbeing across the globe. In the coming decade, vaccines are projected to save the lives of twentyfive million people, [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Helmi Ernandes
Oral Presentation (Virtual)
Helmi Ernandes, Mohamed Kassab Institute of Orthopedics, Tunisia

Background: Chronic osteomyelitis is notoriously difficult to eradicate with multiple clinical failures and relapses after periods of quiescence and apparently successful treatment. The fact that certain bacteria form biofilm with metabolically inactive colonies contributes to [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Binita Roy Nandi
Oral Presentation (Virtual)
Binita Roy Nandi, National Institute of Animal Biotechnology, India

Toll-like receptors are essential components of innate immunity that serve as the first line of defence against invaded microorganisms. However, successful infectious pathogens subvert TLR signalling to suppress the activation of innate and adaptive responses. Brucella species ar [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ndifontiayong Adamu Ndongho
Oral Presentation (Virtual)
Ndifontiayong Adamu Ndongho, Dschang University, Cameroon

Hepatitis B (HBV) and C (HCV) are two among other forms of infections for which co-infection in HIV has been associated with alteration of the immune response,  increased risk of progression to liver diseases and increased risk of hepatotoxicity associated to antiretroviral [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Leana Rich Herrera-Ong
Oral Presentation (Virtual)
Leana Rich Herrera-Ong, University of the Philippines Manila, Philippines

Avian influenza (AI), commonly known as bird flu, is caused by influenza A viruses (IAV) that circulate in humans, horses, dogs, swine, and birds [1]. AI has captured the attention of international and local communities over the years due to its devastating consequences to the he [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Ahlam Abdulsalam Albahloul Almabrouk
Oral Presentation (Virtual)
Ahlam Abdulsalam Albahloul Almabrouk, College of Pharmacy University of Gharyan, Libyan Arab Jamahiriya

Background: Cutaneous leishmaniasis (CL) is endemic in many regions of the world, and has a significant economic and health impacts. Despite the numerous proposed therapies for this zoonotic parasitic disease. Currently, there is no definitive cure for CL. Meglumine antimony comp [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Sisay Shewasinad Yehualashet
Oral Presentation (Virtual)
Sisay Shewasinad Yehualashet, Debre Berhan University, Ethiopia

Introduction: Coronavirus disease 2019 (COVID-19) is an emerging respiratory infections and is known to cause illness ranging from the common cold to severe acute respiratory syndrome. At present, the disease has been posing a serious threat to the communities, and it is critical [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Moges Ayalew Kassaw
Oral Presentation (Virtual)
Moges Ayalew Kassaw, Debre Tabor Health Science College, Ethiopia

Hepatitis is an infectious liver disease caused by the Hepatitis B virus. The Hepatitis B virus can remain in the body after infection during pregnancy, vertically transmit to the foetus, and cause chronic liver damage. Regarding this, immunization during pregnancy stops this ver [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Syra Dhillon
Poster Presentation (Virtual)
Syra Dhillon, University Hospitals Sussex NHS Foundation Trust, United Kingdom

Gram negative bacteria (GNB) are the most common cause of healthcare-associated bacteraemias, most commonly caused by Escherichia coli, Klebsiella and Pseudomonas. GNB carry significant mortality and morbidity, therefore prompt and appropriate antibiotic therapy is important. How [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Jernell Robert D. Malixi
Poster Presentation (Virtual)
Jernell Robert D. Malixi, Philippine Medical Association, Philippines

Background: Hospital Acquired Pneumonia is an important public health concern. Even with the advent of new anti-bacterials, there is an increasing prevalence of anti-microbial resistance worldwide. In particular, Ventilator Acquired Pneumonia can increase mortality risk in patie [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Hamoud Salem Aledhi Alrashidi
Poster Presentation (Virtual)
Hamoud Salem Aledhi Alrashidi, King Salman Hospital, Saudi Arabia

Background In December 2019, the coronavirus disease 2019 (COVID-19) first became identified in the market places of Wuhan, China. The first incidence of COVID-19 was identified in Saudi Arabia on March 2, 2020, and then within a month, the total number of reported instances ha [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Qin Sun
Poster Presentation (Virtual)
Qin Sun, Southeast University, China

Background and objective: Mesenchymal stem cells (MSC) can alleviate the damage of structure and function of pulmonary vascular endothelial cells (VEC). But therapeutic effects of MSC are different among sepsis-induced acute respiratory distress syndrome (ARDS) patients. MicroRNA [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Harshavardhini Kommavarapu
Poster Presentation (Virtual)
Harshavardhini Kommavarapu, International Medical Graduate, India

Introduction: Tularemia is an uncommon disease. An average of 173 cases per year were reported in the US for the past 20 years.(1) A low minimal-infective-dose, high rate of dissemination and the possible mortality make tularemia a potential weapon for bioterrorism.(2) This repo [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Surega D
Poster Presentation (Virtual)
Surega D, Madras medical college, India

BACKGROUND: Nasal cavity tuberculosis is rare, but it can be caused by either a pulmonary disease or retrograde involvement of the nose by lupus vulgaris of the facial skin. Here  we are going to present a rare case of nasal cavity tuberculosis. PRESENTATION AND MANAGE [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Cintia Cevallos
Poster Presentation (Virtual)
Cintia Cevallos, University of Buenos Aires INBIRS, Argentina

Background. The novel coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 is severe and involves multiple organs in approximately 5%-10% of patients, leading to multi-organ dysfunction and failure. Methods. Necropsy tissues (lungs, heart, liver, kidney, small-intestine) we [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Armin Mehmedovic
Poster Presentation (Virtual)
Armin Mehmedovic, University Hospital for Infectious Diseases, Croatia (Hrvatska)

Purpose: To evaluate the value of modified Brixia scoring system in predicting mortality in hospitalized COVID-19 patients. Methods and materials: An observational retrospective pilot study included 292 patients (178 male and 114 female) with PCR-confirmed COVID-19 infection h [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Jalil Nejati
Poster Presentation (Virtual)
Jalil Nejati, Zahedan University of Medical Sciences, Iran (Islamic Republic of)

Nowadays, the rapid expansion of dengue fever vectors, Aedes albopictus and  Ae.aegypti, around the globe has been warned by various documents. In recent years, the eastern neighbor of Iran, Pakistan, has been involved with dengue outbreaks, and the risk of the entrance of t [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Seyyed Mohammad Amin Mousavi Sagharchi
Poster Presentation (Virtual)
Seyyed Mohammad Amin Mousavi Sagharchi, Islamic Azad University, Iran (Islamic Republic of)

Introduction: Protozoa are unicellular and eukaryotic microorganisms. Despite the simple cellular structure, they can destroy the host’s body during its parasitic life, especially when this life contains symbiosis with one or more other microorganisms. Protozoa have receive [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Kaila Petronila Medina Alarcon
Poster Presentation (Virtual)
Kaila Petronila Medina Alarcon, Universidade Estadual Paulista (UNESP), Peru

Background: Periprosthetic joint infection (PJI) is the most common and feared arthroplasty complication. Ralstonia pickettii is an opportunistic Gram-negative bacterium, causing nosocomial infections in immunocompromised patients. It is an environmental bacterium that has been [....] » Read More

Speaker at World Congress on Infectious Diseases 2023 - Larabe Farrukh
Poster Presentation (Virtual)
Larabe Farrukh, Albany Medical Center, United States

PURPOSE: Multisystem Inflammatory Syndrome (MIS) is a severe inflammatory response, that occurs days to weeks following the infection of SARS-CoV2, the virus responsible for COVID -19. Initially known in children and named MIS-C, recently several cases of MIS in adults have bee [....] » Read More

Watsapp